Prosecutors say a network of illegal drug sellers established fake pharmacies that sold pills laced with fentanyl and methamphetamine, leading to nine deaths, The New York Times reported Sept. 30. 

Becker's asked pharmacy executives from hospitals and health systems across the U.S. to share their team's evolving roles and skills.

Dana Filmore, a grandmother from Columbus, Ohio, is among thousands of plaintiffs filing a federal lawsuit against pharmaceutical companies Novo Nordisk and Eli Lilly, alleging Ozempic and Mounjaro caused gastroparesis, USA Today reported Sept. 27. 

The FDA approved selpercatinib for treatment of metastatic medullary thyroid cancer in patients 2 years and older with a RET mutation. 

If there’s a predominant trend in healthcare today, it’s that health systems are getting larger. Whether it’s the result of merger and acquisition activity or organic growth, health systems are increasingly expanding across broad geographic regions.

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations related to misleading claims about a clinical trial for its Alzheimer's disease…

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. 

In the wake of 2023 walkouts by pharmacy workers dubbed "pharmageddon," major chains such as Walgreens and CVS are facing increased pressure from their employees to provide better working conditions and wages. 

AbbVie's tavapadon has demonstrated positive results as a monotherapy for early Parkinson's disease, according to a Sept. 26 news release from the drugmaker. 

The rise of more transparent, "Cost Plus" pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs.